US Broker Ratings

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Unpacking the 12.25% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector, operates within the medical devices industry and boasts a market capitalization of $14.04 billion. With a..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring the 32.84% Potential Upside

AptarGroup, Inc. (ATR) stands as a notable player in the healthcare sector, particularly within the medical instruments and supplies industry. Based in the United States, this innovative company boasts a..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating a 10.37% Potential Upside in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO) is a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $5.34 billion, the..

Repligen Corporation (RGEN) Stock Analysis: Navigating a 15% Potential Upside with Robust Revenue Growth

Repligen Corporation (NASDAQ: RGEN) has emerged as a formidable player in the healthcare sector, specifically within the Medical Instruments & Supplies industry. This Massachusetts-based life sciences company specializes in bioprocessing..

Baxter International Inc. (BAX) Investor Outlook: Analyzing Growth Potential and Valuation Metrics

Baxter International Inc. (NYSE: BAX) operates within the healthcare sector, specifically in the medical instruments and supplies industry. As a stalwart in healthcare solutions, Baxter International has established itself as..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Strong Buy Ratings and a 22.81% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO) has emerged as a compelling player in the biotechnology sector with a market capitalization of $13.13 billion. Headquartered in Palo Alto, California, the company is..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Promising 8.05% Upside in the Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) presents a compelling opportunity within the biotechnology industry, a sector renowned for its innovation and rapid growth. With a market capitalization of $8.27 billion, Halozyme..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Biotech Terrain with a 5.25% Potential Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands at the forefront of the biotechnology sector, particularly in the niche of RNA-targeted therapeutics and gene therapies aimed at treating rare diseases. Headquartered in..

Cencora, Inc. (COR) Stock Analysis: Exploring a Strong Return on Equity and Growth Prospects in Healthcare Distribution

Cencora, Inc. (NYSE: COR), a leading player in the healthcare sector, has been capturing investor interest thanks to its robust financial performance and strategic positioning in the medical distribution industry...

Solventum Corporation (SOLV) Stock Analysis: Navigating Healthcare Innovation with a Strong 37.27% ROE

Solventum Corporation (NYSE: SOLV), a burgeoning player in the healthcare sector, is capturing investor attention with its innovative portfolio and robust financial performance. The company, with a market capitalization of..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Unpacking the 19.87% Potential Upside in Biotech Innovation

Cytokinetics, Incorporated (NASDAQ: CYTK), a pioneering name in the biotechnology sector, stands out with its innovative approach to muscle activators and inhibitors, targeting debilitating diseases with significant unmet medical needs...

Teva Pharmaceutical Industries (TEVA): Investor Outlook on a Potential 15.23% Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a prominent name in the healthcare sector, stands as a global leader in the production and distribution of generic and specialty medicines. Based in..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Deep Look Into Its 38.61% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX), a key player in the biotechnology sector, is capturing investor attention with its significant potential upside of 38.61%. Based in Morrisville, North Carolina, the company..

Madrigal Pharmaceuticals (MDGL) Investor Outlook: Navigating Biotech Upside with 362% Revenue Growth

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has been capturing attention in the biotechnology sector with its impressive financial trajectory and innovative approach to treating metabolic dysfunction-associated steatohepatitis (MASH). This Pennsylvania-based company..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: A Healthcare Giant with a 21.71% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a venerable name in the pharmaceutical industry, offers a promising opportunity for investors seeking exposure to the healthcare sector. With a market capitalization of..

HCA Healthcare, Inc. (HCA) Stock Analysis: Evaluating Growth and Investor Ratings in the Healthcare Sector

HCA Healthcare, Inc. (HCA) stands as a formidable player in the healthcare sector, a fact underscored by its substantial market capitalization of $114.89 billion. This American healthcare giant, headquartered in..

Prestige Consumer Healthcare Inc. (PBH): Investor Outlook Reveals 31% Potential Upside Amid Robust Analyst Support

Prestige Consumer Healthcare Inc. (NYSE: PBH), a prominent player in the over-the-counter (OTC) healthcare space, has caught the attention of investors with a compelling growth narrative and strong analyst support...

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Unpacking a 44.98% Potential Upside for Investors

For investors keen on healthcare stocks, Lantheus Holdings, Inc. (NASDAQ: LNTH) presents an intriguing proposition. With its diverse portfolio in diagnostic and therapeutic products, Lantheus is a key player in..

Waters Corporation (WAT) Stock Analysis: Navigating Market Dynamics with Strong Revenue Growth and Strategic Positioning

Waters Corporation (NYSE: WAT), a stalwart in the Healthcare sector and a leader in the Diagnostics & Research industry, offers intriguing opportunities for investors despite current valuation challenges. With a..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Unveiling a 4.44% Growth Potential in the Healthcare Sector

Thermo Fisher Scientific Inc. (NYSE: TMO) stands as a formidable entity within the healthcare sector, particularly in the diagnostics and research industry. With a robust market capitalization of $220.72 billion,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds